HEPATOTOXICITY OF FLUOROURACIL WITH N-PHOSPHONACETYL-L-ASPARTATE

被引:0
作者
STENRAM, U
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:90 / 91
页数:2
相关论文
共 50 条
[21]   UNEXPECTED SYNERGY BETWEEN N-PHOSPHONACETYL-L-ASPARTATE AND CYTIDINE AGAINST HUMAN-TUMOR CELLS [J].
CHAN, TCK ;
HOWELL, SB .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (04) :721-727
[22]   PLASMA URIDINE CHANGES IN CANCER-PATIENTS TREATED WITH THE COMBINATION OF DIPYRIDAMOLE AND N-PHOSPHONACETYL-L-ASPARTATE [J].
CHAN, TCK ;
MARKMAN, M ;
CLEARY, S ;
HOWELL, SB .
CANCER RESEARCH, 1986, 46 (06) :3168-3172
[23]   COMPARISON OF VANTHOFF AND CALORIMETRICALLY DETERMINED ENTHALPIES OF BINDING OF N-PHOSPHONACETYL-L-ASPARTATE TO ESCHERICHIA-COLI ASPARTATE-TRANSCARBAMYLASE [J].
HOFMANN, GE ;
KNIER, BL ;
ALLEWELL, NM .
BIOPHYSICAL CHEMISTRY, 1979, 10 (01) :47-54
[24]   Phase II study of N-phosphonacetyl-L-aspartate, recombinant interferon-alpha, and fluorouracil infusion in advanced squamous cell carcinoma of the head and neck [J].
Langer, CJ ;
Schaebler, D ;
Sauter, E ;
DeMaria, D ;
Johnson, C ;
Reilly, DM ;
Clark, J ;
Leighton, J ;
Aks, C ;
Litwin, S ;
Ridge, JA .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1998, 20 (05) :385-391
[25]   FLUX THROUGH THE DENOVO PYRIMIDINE PATHWAY INVIVO - EFFECT OF N-PHOSPHONACETYL-L-ASPARTATE, A POTENT INHIBITOR OF ASPARTATE-TRANSCARBAMYLASE [J].
MONKS, A ;
ANDERSON, LW ;
STRONG, J ;
CYSYK, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1983, 258 (22) :3564-3569
[26]   MODULATION OF THE ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL AND CISPLATINUM BY N-PHOSPHONACETYL-L-ASPARTATE IN THE MURINE COLON-CARCINOMA NUMBER-26 [J].
DURRANI, FA ;
CAO, SS ;
VANLAAR, JAM ;
RUSTUM, YM .
INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 5 (05) :1065-1068
[27]   PLASMA URIDINE LEVELS IN CANCER-PATIENTS TREATED WITH DIPYRIDAMOLE (DP) AND N-PHOSPHONACETYL-L-ASPARTATE (PALA) [J].
CHAN, TCK ;
MARKMAN, M ;
HOWELL, SB .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR) :157-157
[28]   Topical N-phosphonacetyl-l-aspartate is a dual action candidate for treating non- melanoma skin cancer [J].
Mahen, Kala K. ;
Markley, Lilian ;
Bogart, Jolie ;
Klatka, Hope ;
Krishna, Vijay ;
Maytin, Edward V. ;
Stark, George R. ;
McDonald, Christine .
EXPERIMENTAL DERMATOLOGY, 2023, 32 (09) :1485-1497
[29]   HOMOTROPIC EFFECTS IN ASPARTATE TRANSCARBAMOYLASE - WHAT HAPPENS WHEN THE ENZYME BINDS A SINGLE MOLECULE OF THE BISUBSTRATE ANALOG N-PHOSPHONACETYL-L-ASPARTATE [J].
FOOTE, J ;
SCHACHMAN, HK .
JOURNAL OF MOLECULAR BIOLOGY, 1985, 186 (01) :175-184
[30]   BIOCHEMICAL INTERACTIONS BETWEEN N-(PHOSPHONACETYL)-L-ASPARTATE AND 5-FLUOROURACIL [J].
LIANG, CM ;
DONEHOWER, RC ;
CHABNER, BA .
MOLECULAR PHARMACOLOGY, 1982, 21 (01) :224-230